Serial Number | 97262974 |
Word Mark | CHIVAX |
Filing Date | Friday, February 11, 2022 |
Status | 719 - REQUEST FOR SECOND EXTENSION - FILED |
Status Date | Thursday, April 25, 2024 |
Registration Number | 0000000 |
Registration Date | NOT AVAILABLE |
Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
Published for Opposition Date | Tuesday, May 2, 2023 |
Goods and Services | Vaccine platform, namely, vaccines used in the prevention and treatment of infectious diseases and cancers; pharmaceutical preparations with antiviral and anticancer properties for use in the treatment of adenovirus; vaccines for human use; human vaccine preparations; therapeutic vaccines for human use |
Goods and Services | Biomedical research services; research and development of vaccines and medicines; research, development, engineering and testing services in the fields of immuno pharmaceuticals and vaccines; scientific research; scientific research in the field of vaccines; clinical and pre-clinical development services in the nature of scientific research and conducting clinical trials for others in the fields of infectious diseases and cancers |
International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
Class Status Code | 6 - Active |
Class Status Date | Wednesday, February 16, 2022 |
Primary Code | 005 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
US Class Codes | 100, 101 |
Class Status Code | 6 - Active |
Class Status Date | Wednesday, March 29, 2023 |
Primary Code | 042 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
Party Name | Virion Therapeutics, LLC |
Party Type | 20 - Owner at Publication |
Legal Entity Type | 16 - Limited Liability Company |
Address | Newark, DE 19711 |
Party Name | Virion Therapeutics, LLC |
Party Type | 10 - Original Applicant |
Legal Entity Type | 16 - Limited Liability Company |
Address | Newark, DE 19711 |
Event Date | Event Description |
Tuesday, February 15, 2022 | NEW APPLICATION ENTERED |
Wednesday, February 16, 2022 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
Monday, November 28, 2022 | ASSIGNED TO EXAMINER |
Tuesday, December 6, 2022 | NON-FINAL ACTION WRITTEN |
Tuesday, December 6, 2022 | NON-FINAL ACTION E-MAILED |
Tuesday, December 6, 2022 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
Friday, March 3, 2023 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
Friday, March 3, 2023 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
Saturday, March 4, 2023 | TEAS/EMAIL CORRESPONDENCE ENTERED |
Wednesday, March 29, 2023 | APPROVED FOR PUB - PRINCIPAL REGISTER |
Wednesday, April 12, 2023 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
Tuesday, May 2, 2023 | PUBLISHED FOR OPPOSITION |
Tuesday, May 2, 2023 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
Tuesday, June 27, 2023 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
Monday, September 25, 2023 | SOU TEAS EXTENSION RECEIVED |
Monday, September 25, 2023 | SOU EXTENSION 1 FILED |
Monday, September 25, 2023 | SOU EXTENSION 1 GRANTED |
Wednesday, September 27, 2023 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
Thursday, April 25, 2024 | SOU TEAS EXTENSION RECEIVED |
Thursday, April 25, 2024 | SOU EXTENSION 2 FILED |
Thursday, April 25, 2024 | SOU EXTENSION 2 GRANTED |
Friday, April 26, 2024 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
Friday, November 22, 2024 | SOU TEAS EXTENSION RECEIVED |